\-\ Texto\\:\\ \ \(0\)\
\-\ normal\ \(4026\)\
\-\ patients\\ with\\ normal\\ stop\\ criteria\\ can\\ be\\ screened\\ annually\\.\ \(0\)\
\-\ using\\ tcd\\ study\\,\\ the\\ patient\\ is\\ risk\\ stratified\\ based\\ on\\ tammx\\(time\\ averaged\\ mean\\ of\\ the\\ maximum\\ velocity\\)\\ values\\.\\ \ \(0\)\
\-\ 1\\.\\ tammx\\ \\<170\\ cm\\/s\\ \\-\\ normal\\,\\ low\\ risk\ \(0\)\
\-\ 2\\.\\ tammx\\ 170\\ \\-199\\ cm\\/s\\ \\-\\ conditional\\,\\ moderate\\ risk\ \(0\)\
\-\ 3\\.\\ tammx\\ \\>200\\ cm\\/s\\ \\-\\ abnormal\\,\\ high\\ risk\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ for\\ this\\ patient\\,\\ tammx\\ values\\ for\\ the\\ intracranial\\ carotid\\ artery\\,\\ middle\\ cerebral\\,\\ and\\ anterior\\ cerebral\\ all\\ fall\\ within\\ the\\ normal\\,\\ low\\ risk\\ category\\.\ \(0\)\
\-\ this\\ patients\\ tcd\\ results\\ place\\ her\\ in\\ the\\ \\"normal\\"\\ category\\ described\\ by\\ stop\\.\ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ patient\\ is\\ a\\ 5\\ y\\/o\\ african\\ american\\ female\\ with\\ an\\ established\\ diagnosis\\ of\\ sickle\\ cell\\ anemia\\ presenting\\ for\\ a\\ annual\\ screening\\.\ \(0\)\
\-\ tcd\\ and\\ stop\\ criteria\\ remain\\ an\\ adequate\\ screening\\ tool\\.\\ \\ \\ mra\\ is\\ more\\ sensitive\\ distinguish\\ stroke\\ risk\\ among\\ patients\\ with\\ abnormal\\ tcd\\ values\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ tammx\\:\\ 0\\.5388369719509488\ \(0\)\
\-\ tcd\\:\\ 0\\.41190999449804994\ \(0\)\
\-\ risk\\:\\ 0\\.28889802065516706\ \(0\)\
\-\ stop\\:\\ 0\\.2352370678111412\ \(0\)\
\-\ values\\:\\ 0\\.18647788540334\ \(0\)\
\-\ 170\\:\\ 0\\.15997961442588937\ \(0\)\
\-\ category\\:\\ 0\\.154933568992046\ \(0\)\
\-\ normal\\:\\ 0\\.13756946443910234\ \(0\)\
\-\ criteria\\:\\ 0\\.13365097982216143\ \(0\)\
\-\ patients\\:\\ 0\\.1137275802717889\ \(0\)\
\-\ screening\\:\\ 0\\.10948324495525978\ \(0\)\
\-\ conditional\\:\\ 0\\.10776739439018974\ \(0\)\
\-\ stratified\\:\\ 0\\.10297749862451248\ \(0\)\
\-\ averaged\\:\\ 0\\.10297749862451248\ \(0\)\
\-\ cerebral\\:\\ 0\\.09337345406090193\ \(0\)\
\-\ screened\\:\\ 0\\.08999922196301341\ \(0\)\
\-\ annually\\:\\ 0\\.08875456273654216\ \(0\)\
\-\ tool\\:\\ 0\\.08477970297862195\ \(0\)\
\-\ velocity\\:\\ 0\\.08181084106719161\ \(0\)\
\-\ abnormal\\:\\ 0\\.0809710991582407\ \(0\)\
\-\ low\\:\\ 0\\.07733470480144242\ \(0\)\
\-\ mean\\:\\ 0\\.07429769174851396\ \(0\)\
\-\ 200\\:\\ 0\\.07429769174851396\ \(0\)\
\-\ distinguish\\:\\ 0\\.07298374589227247\ \(0\)\
\-\ established\\:\\ 0\\.07267688873034574\ \(0\)\
\-\ maximum\\:\\ 0\\.0715234526329377\ \(0\)\
\-\ among\\:\\ 0\\.07125186971791639\ \(0\)\
\-\ remain\\:\\ 0\\.0681938501265952\ \(0\)\
\-\ the\\:\\ 0\\.0672313096841547\ \(0\)\
\-\ sickle\\:\\ 0\\.06664233373819721\ \(0\)\
\-\ mra\\:\\ 0\\.06664233373819721\ \(0\)\
\-\ sensitive\\:\\ 0\\.06628432644651597\ \(0\)\
\-\ patient\\:\\ 0\\.0657533805477826\ \(0\)\
\-\ adequate\\:\\ 0\\.06559930345852424\ \(0\)\
\-\ stroke\\:\\ 0\\.062667473980277\ \(0\)\
\-\ annual\\:\\ 0\\.062284305152967796\ \(0\)\
\-\ anemia\\:\\ 0\\.061913175054957484\ \(0\)\
\-\ for\\:\\ 0\\.06127396566421198\ \(0\)\
\-\ african\\:\\ 0\\.060864999967257485\ \(0\)\
\-\ place\\:\\ 0\\.060754075804751\ \(0\)\
\-\ american\\:\\ 0\\.057494409387290536\ \(0\)\
\-\ carotid\\:\\ 0\\.05676345442139547\ \(0\)\
\-\ fall\\:\\ 0\\.056149636540367066\ \(0\)\
\-\ using\\:\\ 0\\.055424664525479256\ \(0\)\
\-\ is\\:\\ 0\\.05536363144522796\ \(0\)\
\-\ described\\:\\ 0\\.05467544114761109\ \(0\)\
\-\ intracranial\\:\\ 0\\.054222271306567905\ \(0\)\
\-\ presenting\\:\\ 0\\.05278859466347528\ \(0\)\
\-\ results\\:\\ 0\\.052510620979290094\ \(0\)\
\-\ an\\:\\ 0\\.051537560961388874\ \(0\)\
\-\ moderate\\:\\ 0\\.05058798320751644\ \(0\)\
\-\ based\\:\\ 0\\.048813734905555066\ \(0\)\
\-\ middle\\:\\ 0\\.04818771631441938\ \(0\)\
\-\ this\\:\\ 0\\.046311165052294816\ \(0\)\
\-\ study\\:\\ 0\\.04494265329537127\ \(0\)\
\-\ her\\:\\ 0\\.04209993087779439\ \(0\)\
\-\ artery\\:\\ 0\\.04185216831360989\ \(0\)\
\-\ all\\:\\ 0\\.04011421479889275\ \(0\)\
\-\ time\\:\\ 0\\.0399423119618839\ \(0\)\
\-\ with\\:\\ 0\\.0395859858945252\ \(0\)\
\-\ cell\\:\\ 0\\.03854879462344567\ \(0\)\
\-\ high\\:\\ 0\\.03829867935596748\ \(0\)\
\-\ anterior\\:\\ 0\\.03762528115145234\ \(0\)\
\-\ more\\:\\ 0\\.037002983407113804\ \(0\)\
\-\ can\\:\\ 0\\.035362861764016734\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03493323854530253\ \(0\)\
\-\ female\\:\\ 0\\.03251761053630255\ \(0\)\
\-\ within\\:\\ 0\\.031036636647571544\ \(0\)\
\-\ by\\:\\ 0\\.028616670430902002\ \(0\)\
\-\ and\\:\\ 0\\.027849632542879074\ \(0\)\
\-\ be\\:\\ 0\\.02733644305018086\ \(0\)\
\-\ of\\:\\ 0\\.02637489826758671\ \(0\)\
\-\ on\\:\\ 0\\.020352202761783136\ \(0\)\
\-\ in\\:\\ 0\\.01676384035662331\ \(0\)\
